Following are major stock gainers on Nasdaq in Tuesday’s trading session:
China XD Plastics Company Limited (NASDAQ:CXDC) was the active stock gainer on Tuesday and soared 152% to $0.93. In May, The company announced that as expected, it received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it was not in compliance with requirements of Nasdaq Listing Rule 5250(c)(1) as a result of not having timely filed its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 (the “Form 10-Q”) and because the Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Form 10-K”).
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) was another notable winner as the stock went up 68% to end the session at $58.25 after the company announced that Singapore regulators approved the advancement of two messenger RNA COVID-19 vaccine candidates into phase 1/2 clinical testing.
The Singapore Health Sciences Authority gave the green light for Arcturus to initiate a phase 1/2 clinical trial featuring mRNA vaccine candidates ARCT-154 and ARCT-165. This study will evaluate these candidates as primary vaccines and as boosters following initial vaccination with Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech.
Flora Growth Corp. ((NASDAQ:FLGC) surged 62% to $12.71. Flora Growth Corp., a cannabis company, cultivates, processes, and supplies cannabis products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis oil extracts and related products; manufactures and sells skincare and beauty products, such as gel cleanser, eye cream, moisturizer, and hydrating mask; manufactures dermo cosmetic products; and develops and sells pharmaceutical and over-the-counter products, including dietary supplements, phytotherapeutic and nutraceutical products.
